VERMOX
Active substance: mebendazole
TABLET, CHEWABLE · MEBENDAZOLE 500 mg/1
United StatesActive
Marketing holder: Janssen Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- MEBENDAZOLE · 500 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 10 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-370f-76b7-8c96-48d56281ba5c,01a120c3-40d5-71fd-b01c-77e9f9d299b7,01a120c3-4842-75f4-b333-8b64958db603,01a120c3-64a4-745d-9341-6c3b8cca5c46,01a120c5-1d97-7207-8b91-3c2a81f0dd9a;count=9 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12098-bcbc-7ae9-b6aa-d01071131b79;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50458-675
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50458-675 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50458-675 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50458-675 · Verified 2026-10-09 · open in source